Regenxbio (RGNX) Earnings Call Presentation
RGX-202: AFFINITY DUCHENNE® New Phase I/II Interim Functional Data June 2025 Forward-looking statements This presentation includes "forward-looking statements," within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements express a belief, expectation or intention and are generally accompanied by words that convey projected future events or outcomes such as "believe," "may," "will," "estimate," "continue," " ...